Literature DB >> 23195954

Serine protease activity of calnuc: regulation by Zn2+ and G proteins.

Madhavi Kanuru1, Rajeev Raman, Gopala Krishna Aradhyam.   

Abstract

The functions of calnuc, a novel Ca(2+)-binding protein with multiple structural domains and diverse interacting partners, are yet unknown. We demonstrate unknown facets of calnuc, which is a serine protease in which Ser-378 of GXSXG motif, Asp-328 of DTG motif, and His-339 form the "catalytic triad," locating the enzyme active site in the C-terminal region. Analogous to the active site of Zn(2+) carboxypeptidases, calnuc has two high affinity (K(d) ∼ 20 nm), well conserved Zn(2+)-binding sites near its N terminus, although it is inactive as a peptidase. Zn(2+) binding allosterically and negatively regulates the serine protease activity of calnuc, inhibition being caused by an "open to close" change in its conformation not seen upon Ca(2+) binding. Most strikingly, interaction with G protein α subunit completely inhibits the enzymatic activity of calnuc. We thus illustrate that G proteins and Zn(2+) act as two "keys" that control enzymatic activity of calnuc, arresting it in "locked" state. Calnuc, therefore, exists dynamically in two different forms, (i) as a Ca(2+)-binding protein in Zn(2+)-bound form and (ii) as a protease in Zn(2+)-free form, commissioning it to perform multiple functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23195954      PMCID: PMC3548486          DOI: 10.1074/jbc.M112.382846

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Classification and evolution of EF-hand proteins.

Authors:  H Kawasaki; S Nakayama; R H Kretsinger
Journal:  Biometals       Date:  1998-12       Impact factor: 2.949

2.  The hydrolysis of p-nitrophenyl acetate catalyzed by 3-phosphoglyceraldehyde dehydrogenase crystallized from yeast.

Authors:  E L TAYLOR; B P MERIWETHER; J H PARK
Journal:  J Biol Chem       Date:  1963-02       Impact factor: 5.157

3.  Molecular cloning of nucleobindin, a novel DNA-binding protein that contains both a signal peptide and a leucine zipper structure.

Authors:  K Miura; K Titani; Y Kurosawa; Y Kanai
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

4.  Interaction of the protein nucleobindin with G alpha i2, as revealed by the yeast two-hybrid system.

Authors:  N Mochizuki; M Hibi; Y Kanai; P A Insel
Journal:  FEBS Lett       Date:  1995-10-09       Impact factor: 4.124

5.  Natural occurrence of Nuc in the sera of autoimmune-prone MRL/lpr mice.

Authors:  Y Kanai; K Miura; T Uehara; M Amagai; O Takeda; S Tanuma; Y Kurosawa
Journal:  Biochem Biophys Res Commun       Date:  1993-10-29       Impact factor: 3.575

Review 6.  Metal chelation as a potential therapy for Alzheimer's disease.

Authors:  M P Cuajungco; K Y Fagét; X Huang; R E Tanzi; A I Bush
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

7.  Zn2+ binding to human calbindin D(28k) and the role of histidine residues.

Authors:  Mikael C Bauer; Hanna Nilsson; Eva Thulin; Birgitta Frohm; Johan Malm; Sara Linse
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

Review 8.  Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies.

Authors:  Marcus C Schaub; Claus W Heizmann
Journal:  Biochem Biophys Res Commun       Date:  2007-10-25       Impact factor: 3.575

9.  Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes.

Authors:  S S Twining
Journal:  Anal Biochem       Date:  1984-11-15       Impact factor: 3.365

10.  Ion-binding properties of Calnuc, Ca2+ versus Mg2+--Calnuc adopts additional and unusual Ca2+-binding sites upon interaction with G-protein.

Authors:  Madhavi Kanuru; Jebakumar J Samuel; Lavanya M Balivada; Gopala K Aradhyam
Journal:  FEBS J       Date:  2009-03-19       Impact factor: 5.542

View more
  2 in total

1.  Identification and comparative analysis of hepatitis C virus-host cell protein interactions.

Authors:  Patrick T Dolan; Chaoying Zhang; Sudip Khadka; Vaithilingaraja Arumugaswami; Abbey D Vangeloff; Nicholas S Heaton; Sudhir Sahasrabudhe; Glenn Randall; Ren Sun; Douglas J LaCount
Journal:  Mol Biosyst       Date:  2013-10-18

2.  NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response.

Authors:  Yong-Qiang Hua; Ke Zhang; Jie Sheng; Zhou-Yu Ning; Ye Li; Wei-Dong Shi; Lu-Ming Liu
Journal:  Front Cell Dev Biol       Date:  2021-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.